Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 8/20 | 0.59 |
| ▸ | ADA | P00813 | 1/20 | 0.55 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | PI4KA | P42356 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.54 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.54 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.54 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17833855 | 0.87 | AHCY (0.62) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL6575705 | 0.86 | HIF1A (0.50) | AHCYPOLBADORA3 | |
| SCHEMBL896624 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL29362124 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL5962596 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL23396436 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL5962598 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL284737 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL20794222 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL10015774 | 0.85 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101591-A1 | NOVEL, HEAVY VITAMIN B12 DERIVATIVES | CHARLES STURT UNIVERSITY (AU) | 2024-03-28 | — | — | US | claimed |
| US-11884695-B2 | Heavy vitamin B12 derivatives | CHARLES STURT UNIVERSITY (AU) | 2024-01-30 | — | — | US | claimed |
| US-20230183287-A1 | NOVEL, HEAVY VITAMIN B12 DERIVATIVES | CHARLES STURT UNIVERSITY (AU) | 2023-06-15 | — | — | US | claimed |
| EP-4168009-A1 | CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS | Hangzhou DAC Biotech Co., Ltd. (CN) | 2023-04-26 | — | — | EP | claimed |
| US-11597747-B2 | Heavy vitamin B12 derivatives | CHARLES STURT UNIVERSITY (AU) | 2023-03-07 | — | — | US | claimed |
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-01-12 | — | — | US | claimed |
| EP-3917576-A1 | A CONJUGATE OF AN AMANITA TOXIN WITH BRANCHED LINKERS | Hangzhou Dac Biotech Co., Ltd. (CN) | 2021-12-08 | — | — | EP | claimed |
| WO-2021212638-A1 | CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-10-28 | — | — | WO | claimed |
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-10-07 | — | — | US | claimed |
| US-11129910-B2 | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-09-28 | — | — | US | claimed |
| EP-1066292-B1 | METALLOCORRINOIDS AS BIOLOGICALLY COMPATIBLE CARRIERS OF PHARMACOLOGICAL AGENTS | UNIV AKRON (US) | 2003-03-26 | — | — | EP | claimed |
| US-20020142414-A1 | Process for the preparation of protease inhibitors | UCP GEN-PHARMA AG (CH) | 2002-10-03 | — | — | US | claimed |
| US-20020035087-A1 | B complex vitamin compositions that protect against cellular damage caused by ultraviolet light | BARCLAY BARRY J (CA) | 2002-03-21 | — | — | US | claimed |
| WO-2002003942-A2 | B COMPLEX VITAMIN COMPOSITIONS THAT PROTECT AGAINST CELLULAR DAMAGE CAUSED BY ULTRAVIOLET LIGHT | PLANET BIOTECH INC. (CA) | 2002-01-17 | — | — | WO | claimed |
| EP-1066292-A4 | METALLOCORRINOIDS AS BIOLOGICALLY COMPATIBLE CARRIERS OF PHARMACOLOGICAL AGENTS | UNIV AKRON (US) | 2001-08-16 | — | — | EP | claimed |
| WO-2001014401-A1 | NUCLEOSIDE PYROPHOSPHATE AND TRIPHOSPHATE ANALOGS AND RELATED COMPOUNDS AS THERAPEUTIC AGENTS | SRI INTERNATIONAL (US) | 2001-03-01 | — | — | WO | claimed |
| EP-1066292-A1 | METALLOCORRINOIDS AS BIOLOGICALLY COMPATIBLE CARRIERS OF PHARMACOLOGICAL AGENTS | The University of Akron (US) | 2001-01-10 | — | — | EP | claimed |
| US-5936082-A | Metallocorrinoids as biologically compatible carriers of pharmacological agents | THE UNIVERSITY OF AKRON (US) | 1999-08-10 | — | — | US | claimed |
| WO-1999033833-A1 | METALLOCORRINOIDS AS BIOLOGICALLY COMPATIBLE CARRIERS OF PHARMACOLOGICAL AGENTS | THE UNIVERSITY OF AKRON (US) | 1999-07-08 | — | — | WO | claimed |
| EP-0146785-A1 | Process for the preparation of protease inhibitors | CIBA-GEIGY AG (CH) | 1985-07-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020142414-A1 | Process for the preparation of protease inhibitors | EGLN2, EGLN1, PREP | AHCY 1509/4885ADA 2502/4885STING1 453/4885 |
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | DAO, DDO, DCLRE1A | AHCY 963/4885ADA 2072/4885STING1 4724/4885 |
| US-11129910-B2 | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | SLC25A1, GCDH, FH | AHCY 1556/4885ADA 3815/4885STING1 3524/4885 |
| US-20230183287-A1 | NOVEL, HEAVY VITAMIN B12 DERIVATIVES | HMBS, SLC19A1, SLC19A2 | AHCY 21/4885ADA 620/4885STING1 4379/4885 |
| US-20240101591-A1 | NOVEL, HEAVY VITAMIN B12 DERIVATIVES | HMBS, SLC19A1, SLC19A2 | AHCY 21/4885ADA 620/4885STING1 4379/4885 |
| US-20020035087-A1 | B complex vitamin compositions that protect against cellular damage caused by ultraviolet light | MAOB, S100A9, CCNB3 | AHCY 346/4885ADA 436/4885STING1 803/4885 |
| US-11884695-B2 | Heavy vitamin B12 derivatives | HMBS, SLC19A1, SLC19A2 | AHCY 44/4885ADA 629/4885STING1 4493/4885 |
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | CD2BP2, DCLRE1A, EPCAM | AHCY 1802/4885ADA 3917/4885STING1 4850/4885 |
| US-11597747-B2 | Heavy vitamin B12 derivatives | HMBS, SLC19A1, SLC19A2 | AHCY 44/4885ADA 629/4885STING1 4493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.